![](https://cdn.sanity.io/images/0vv8moc6/onclive/23bab2684eb49de3b5714fa7f225436e412caac6-262x145.jpg?fit=crop&auto=format)
Dr Davis on the Utility of ADCs in Breast Cancer
Andrew Davis, MD, assistant professor, medicine, Division of Medical Oncology, Washington University School of Medicine, medical oncologist, Siteman Cancer Center, discusses the use of antibody-drug conjugates (ADCs) in patients with breast cancer, …